Mesoblast Ltd operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mesoblast Ltd with three other
companies in this sector in Australia:
sales of 2.76 million Australian Dollars [US$2.20 million]
Starpharma Holdings Limited
(3.65 million Australian Dollars [US$2.90 million]
of which 100%
was Dendritic), and
Oncosil Medical Ltd
(3.76 million Australian Dollars [US$2.99 million]
Sales fell dramatically in 2017:
During the year ended June of 2017, sales at
Mesoblast Ltd were A$3.20 million (US$2.55 million).
decrease of 94.5%
versus 2016, when the company's sales were A$58.52 million.